Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes

BMC Nephrology

Volumn 16, Issue 1, 2015, Pages

  Tseng, Chin Lin ^a,b   Lafrance, Jean Philippe ^c   Lu, Shou En ^d   Soroka, Orysya ^a   Miller, Donald R ^e,f   Maney, Miriam ^a   Pogach, Leonard M ^a,b  

^a Department of Veteran Affairs New Jersey Health Care System Mail Stop15 ^*  (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f BOSTON UNIVERSITY   (United States)

Author keywords

Chronic kidney disease; Diabetes; Dialysis; Glomerular filtration rate; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DISEASE COURSE; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; VETERANS HEALTH; AGE; CAUSE OF DEATH; COMPARATIVE STUDY; DIABETIC NEPHROPATHIES; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME; DEATH; DIABETIC PATIENT; DIALYSIS; KIDNEY FUNCTION; OUTCOME ASSESSMENT; RISK; TIME; VETERAN;

AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84925822727     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-015-0025-5     Document Type: Article

References (43)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-305.
2. U.S. Renal Data System. USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2011.
3. Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008;52(4):661-71.
4. Onuigbo MA. The natural history of chronic kidney disease revisited-a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection. Adv Perit Dial. 2009;25:85-8.
5. Zhang AH, Tam P, LeBlanc D, Zhong H, Chan CT, Bargman JM, et al. Natural history of CKD stage 4 and 5 patients following referral to renal management clinic. Int Urol Nephrol. 2009;41(4):977-82.
6. Barrett BJ, Garg AX, Goeree R, Levin A, Molzahn A, Rigatto C, et al. A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol. 2011;6(6):1241-7.
7. Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, et al. Rate of kidney function decline associates with mortality. J Am Soc Nephrol. 2010;21(11):1961-9.
8. Hoefield RA, Kalra PA, Baker P, Lane B, New JP, O'Donoghue DJ, et al. Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis. 2010;56(6):1072-81.
9. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553-9.
10. Ambrogi V, Thilly N, Boini S, Virion JM, Kessler M, Briancon S, et al. Patterns and predictors of kidney function decline in the last year prior to dialysis. Nephron Clin Pract. 2009;111(12):c95-101.
11. Heaf JG, Mortensen LS. Uraemia progression in chronic kidney disease stages 3-5 is not constant. Nephron Clin Pract. 2011;118(4):c367-74.
12. Li L, Astor BC, Lewis J, Appel LJ, Lipkowitz MS, Toto RD, et al. Longitudinal Progression Trajectory of GFR Among Patients With CKD. Am J Kidney Dis. 2012;59(4):504-12.
13. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007;18(4):1292-8.
14. Ishani A, Xue JL, Himmelfarb J, Prescott G, Townend J, Smith W, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20(1):223-8.
15. Lafrance JP, Djurdjev O, Levin A. Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort. Nephrol Dial Transplant. 2010;25(7):2203-9.
16. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994;330(13):877-84.
17. Wright J, Barkis G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al. African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288(19):2421-31.
18. Gassman JJ, Greene T, Wright Jr JT, Agodoa L, Bakris G, Beck GJ, et al. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol. 2003;14 Suppl 2:S154-65.
19. Al-Aly Z, Balasubramanian S, McDonald JR, Scherrer JF, O'Hare AM. Greater variability in kidney function is associated with an increased risk of death. Kidney Int. 2012;82(11):1208-2014.
20. Moen MF, Zhan M, Hsu VD, Walker LD, Einhorn LM, Seliger SL, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1121-7.
21. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27 Suppl 2:B10-21.
22. Kern EFO, Maney M, Miller DR, Tseng CL, Tiwari A, Rajan M, et al. Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Health Serv Res. 2006;41(2):564-80.
23. Tseng CL, Kern EFO, Miller D, Tiwari A, Maney M, Rajan M, et al. Survival Benefit of Nephrologic Care in Patients with Diabetes and Chronic Kidney Disease. Arch Intern Med. 2008;168(1):55-62.
24. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.
25. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-54.
26. U.S. Department of Veterans Affairs, VA Information Resource Center (VIReC). VHA Vital Status File. (http://www.hsrd.research.va.gov/for-researchers/cyber-seminars/archives/694-notes.pdf). (Accessed January 20, 2015).
27. U.S. Department of Veterans Affairs. Health Benefits: priority group table. (http://www.va.gov/healthbenefits/resources/priority-groups.asp). (Accessed January 20, 2015).
28. Selim AJ, Fincke G, Ren XS, Lee A, Rogers WH, Miller DR, et al. Comorbidity assessments based on patient report: results from the Veterans Health Study. J Ambul Care Manage. 2004;27(3):281-95.
29. Yang W, Israni RK, Brunelli SM. Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol. 2007;18(12):3164-70.
30. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011;57(2):160-6.
31. Mazzeo AT, La Monaca E, Di Leo R, Vita G, Santamaria LB. Heart rate variability: a diagnostic and prognostic tool in anesthesia and intensive care. Acta Anaesthesiol Scand. 2011;55(7):797-811.
32. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension. 2012;59(2):212-8.
33. Takao T, Matsuyama Y, Yanagisawa H, Kikuchi M, Kawazu S. Association between HbA1c variability and mortality in patients with type 2 diabetes. J Diabetes Complications. 2014;28(4):494-9.
34. Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH. Finnish Diabetic Nephropathy Study. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes. 2009;58(11):2649-55.
35. Musso CG. Renal reserve test: its methodology and significance. Saudi J Kidney Dis Transpl. 2011;22(5):990-3.
36. Barai S, Gambhir S, Prasad N, Sharma RK, Ora M. Functional renal reserve capacity in different stages of chronic kidney disease. Nephrology (Carlton). 2010;15(3):350-3.
37. Schell JO, Patel UD, Steinhauser KE, Ammarell N, Tulsky JA. Discussions of the kidney disease trajectory by elderly patients and nephrologists: a qualitative study. Am J Kidney Dis. 2012;59(4):495-503.
38. Levin A, Djurdjev O. On being better kidney doctors: understanding trajectories, probabilities, predictability, and people. Am J Kidney Dis. 2012;59(4):475-7.
39. Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J. Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol. 2009;20:2617-24.
40. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, et al. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int. 2013;83(4):684-91.
41. Perkins RM, Tang X, Bengier AC, Kirchner HL, Bucaloiu ID. Variability in estimated glomerular filtration rate is an independent risk factor for death among patients with stage 3 chronic kidney disease. Kidney Int. 2012;82(12):1332-8.
42. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, et al. Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant. 2012;27(10):3835-43.
43. Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease. Clin Nephrol. 2013;80(4):256-62.